Historical Valuation
Fresenius Medical Care AG (FMS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.40 is considered Undervalued compared with the five-year average of 13.96. The fair price of Fresenius Medical Care AG (FMS) is between 28.26 to 42.45 according to relative valuation methord. Compared to the current price of 22.75 USD , Fresenius Medical Care AG is Undervalued By 19.51%.
Relative Value
Fair Zone
28.26-42.45
Current Price：22.75
19.51%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Fresenius Medical Care AG (FMS) has a current Price-to-Book (P/B) ratio of 0.45. Compared to its 3-year average P/B ratio of 0.71 , the current P/B ratio is approximately -36.69% higher. Relative to its 5-year average P/B ratio of 0.93, the current P/B ratio is about -51.95% higher. Fresenius Medical Care AG (FMS) has a Forward Free Cash Flow (FCF) yield of approximately 15.69%. Compared to its 3-year average FCF yield of 14.36%, the current FCF yield is approximately 9.31% lower. Relative to its 5-year average FCF yield of 13.57% , the current FCF yield is about 15.66% lower.
P/B
Median3y
0.71
Median5y
0.93
FCF Yield
Median3y
14.36
Median5y
13.57
Competitors Valuation Multiple
AI Analysis for FMS
The average P/S ratio for FMS competitors is 2.95, providing a benchmark for relative valuation. Fresenius Medical Care AG Corp (FMS.N) exhibits a P/S ratio of 0.57, which is -80.54% above the industry average. Given its robust revenue growth of 9.17%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for FMS
1Y
3Y
5Y
Market capitalization of FMS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of FMS in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is FMS currently overvalued or undervalued?
Fresenius Medical Care AG (FMS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.40 is considered Undervalued compared with the five-year average of 13.96. The fair price of Fresenius Medical Care AG (FMS) is between 28.26 to 42.45 according to relative valuation methord. Compared to the current price of 22.75 USD , Fresenius Medical Care AG is Undervalued By 19.51% .
What is Fresenius Medical Care AG (FMS) fair value?
FMS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Fresenius Medical Care AG (FMS) is between 28.26 to 42.45 according to relative valuation methord.
How does FMS's valuation metrics compare to the industry average?
The average P/S ratio for FMS's competitors is 2.95, providing a benchmark for relative valuation. Fresenius Medical Care AG Corp (FMS) exhibits a P/S ratio of 0.57, which is -80.54% above the industry average. Given its robust revenue growth of 9.17%, this premium appears unsustainable.
What is the current P/B ratio for Fresenius Medical Care AG (FMS) as of Jan 10 2026?
As of Jan 10 2026, Fresenius Medical Care AG (FMS) has a P/B ratio of 0.45. This indicates that the market values FMS at 0.45 times its book value.
What is the current FCF Yield for Fresenius Medical Care AG (FMS) as of Jan 10 2026?
As of Jan 10 2026, Fresenius Medical Care AG (FMS) has a FCF Yield of 15.69%. This means that for every dollar of Fresenius Medical Care AG’s market capitalization, the company generates 15.69 cents in free cash flow.
What is the current Forward P/E ratio for Fresenius Medical Care AG (FMS) as of Jan 10 2026?
As of Jan 10 2026, Fresenius Medical Care AG (FMS) has a Forward P/E ratio of 9.40. This means the market is willing to pay $9.40 for every dollar of Fresenius Medical Care AG’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Fresenius Medical Care AG (FMS) as of Jan 10 2026?
As of Jan 10 2026, Fresenius Medical Care AG (FMS) has a Forward P/S ratio of 0.57. This means the market is valuing FMS at $0.57 for every dollar of expected revenue over the next 12 months.